-
Ferring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal
inFerring Pharmaceuticals and SK pharmteco enter into commercial gene therapy manufacturing deal…
-
Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring
inLaunch of two first-in-class medicines in 2023 marks start of exciting phase…
-
Ferring announces full availability of ADSTILADRIN® (nadofaragene firadenovec-vncg) in the U.S.
in…
PRESS RELEASE 2024
PRESS RELEASE 2024